Rates of serious postoperative infection and 30-day readmissions after total joint arthroplasty are similar in patients with rheumatoid arthritis (RA) regardless of their exposure to different biologic therapies. However glucocorticoid use is associated with a greater risk of adverse outcomes, suggesting that minimising their use should be a bigger focus for perioperative management. The retrospective ...
Already a member?
Enter your email to keep reading.